Innovation1 Biotech Inc. filed its 10-K on Dec 15, 2022 for the period ending Aug 31, 2022. In this report its auditor, Fruci & Associates II, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | -96.36% |
|
-.--% | -99.07% |
01-17 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-99.07% | 17.98K | |
+87.14% | 5.79B | |
+98.02% | 1.25B | |
+2.57% | 986M | |
+32.87% | 869M | |
+2.20% | 667M | |
+7.72% | 653M | |
-.--% | 600M | |
+10.28% | 536M | |
-.--% | 500M |
- Stock Market
- Equities
- IVBT Stock
- News Innovation1 Biotech Inc.
- Innovation1 Biotech Inc. Auditor Raises 'Going Concern' Doubt